Literature DB >> 3135142

Prostaglandin precursor fatty acids in cirrhosis with ascites: effect of linoleic acid infusion in functional renal failure.

A Rimola1, P Ginés, E Cusó, J Camps, J Gaya, V Arroyo, J Rodés.   

Abstract

1. Functional renal failure (FRF) in cirrhosis with ascites could be related to an inappropriately low renal prostaglandin (PG) production. To investigate whether the impaired renal PG synthesis in these patients is related to a PG precursor fatty acid deficiency, serum levels of linoleic and arachidonic acids and the urinary excretion of PGE2, 6-keto-PGF1 alpha and thromboxane B2 (TxB2) were measured in 10 normal subjects, 17 non-azotaemic cirrhotic patients with ascites and 10 cirrhotic patients with ascites and FRF. 2. Serum linoleic acid levels were similar in the three groups studied. Both groups of cirrhotic patients showed lower arachidonic acid levels than normal subjects; however, non-azotaemic cirrhotic patients and patients with FRF did not differ in relation to serum arachidonic acid. 3. Non-azotaemic cirrhotic patients had higher urinary PGE2, 6-keto-PGF1 alpha and TxB2 excretion than normal subjects and cirrhotic patients with FRF. Patients with FRF showed similar urinary PGE2 and TxB2 and lower urinary 6-keto-PGF1 alpha than normal subjects. In all cirrhotic patients no significant correlation was found between serum linoleic and arachidonic acid levels and urinary PGs. 4. In seven patients with FRF an acute intravenous infusion of linoleic acid induced a marked increase in serum levels of this fatty acid. However, no increase in serum arachidonic acid levels and urinary PG excretion and no improvement in renal function was observed. 5. This study suggests that an arachidonic acid deficiency is present in cirrhotic patients with ascites but that this abnormality is not a major determinant of renal function and PG production in these patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135142     DOI: 10.1042/cs0740613

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  3 in total

1.  Supplementation of arachidonic acid plus docosahexaenoic acid in cirrhotic patients awaiting liver transplantation: a preliminary study.

Authors:  Sassan Pazirandeh; Pei-Ra Ling; Mario Ollero; Fredric Gordon; David L Burns; Bruce R Bistrian
Journal:  JPEN J Parenter Enteral Nutr       Date:  2007 Nov-Dec       Impact factor: 4.016

2.  Reduced brain content of arachidonic acid and docosahexaenoic acid is related to the severity of liver fibrosis.

Authors:  Chih-Cheng Chen; Li-Tung Huang; You-Lin Tain; Hsio-Chi Chaung; Chih-Sung Hsieh; Hock-Liew Eng; Yu-Ching Wei; Chun-Yu Yang
Journal:  Dig Dis Sci       Date:  2010-01-26       Impact factor: 3.199

3.  Abnormalities in the serum phospholipids fatty acid profile in patients with alcoholic liver cirrhosis - a pilot study.

Authors:  Danijela Ristić-Medić; Marija Takić; Vesna Vučić; Dragoslav Kandić; Nada Kostić; Marija Glibetić
Journal:  J Clin Biochem Nutr       Date:  2013-06-07       Impact factor: 3.114

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.